Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1994 1
1995 1
1996 1
1997 2
1998 3
2000 1
2001 1
2002 3
2003 4
2004 2
2005 2
2006 7
2007 2
2009 1
2010 2
2011 4
2012 2
2013 2
2014 1
2015 2
2016 3
2017 1
2018 7
2019 4
2020 4
2021 2
2022 3
2023 5
2024 5
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Preface.
Weimbs T. Weimbs T. Methods Cell Biol. 2019;153:xiii-xiv. doi: 10.1016/S0091-679X(19)30104-9. Methods Cell Biol. 2019. PMID: 31395387 No abstract available.
Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD-a randomized controlled trial.
Cukoski S, Lindemann CH, Arjune S, Todorova P, Brecht T, Kühn A, Oehm S, Strubl S, Becker I, Kämmerer U, Torres JA, Meyer F, Schömig T, Hokamp NG, Siedek F, Gottschalk I, Benzing T, Schmidt J, Antczak P, Weimbs T, Grundmann F, Müller RU. Cukoski S, et al. Among authors: weimbs t. Cell Rep Med. 2023 Nov 21;4(11):101283. doi: 10.1016/j.xcrm.2023.101283. Epub 2023 Nov 7. Cell Rep Med. 2023. PMID: 37935200 Free PMC article. Clinical Trial.
Preface.
Weimbs T. Weimbs T. Methods Cell Biol. 2019;154:xiii-xiv. doi: 10.1016/S0091-679X(19)30115-3. Methods Cell Biol. 2019. PMID: 31493824 No abstract available.
β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease.
Torres JA, Holznecht N, Asplund DA, Kroes BC, Amarlkhagva T, Haeffner MM, Sharpe EH, Koestner S, Strubl S, Schimmel MF, Kruger S, Agrawal S, Aceves BA, Thangaraju M, Weimbs T. Torres JA, et al. Among authors: weimbs t. iScience. 2024 Aug 20;27(9):110773. doi: 10.1016/j.isci.2024.110773. eCollection 2024 Sep 20. iScience. 2024. PMID: 39314240 Free PMC article.
STAT signaling in polycystic kidney disease.
Strubl S, Torres JA, Spindt AK, Pellegrini H, Liebau MC, Weimbs T. Strubl S, et al. Among authors: weimbs t. Cell Signal. 2020 Aug;72:109639. doi: 10.1016/j.cellsig.2020.109639. Epub 2020 Apr 20. Cell Signal. 2020. PMID: 32325185 Free PMC article. Review.
Third-hit signaling in renal cyst formation.
Weimbs T. Weimbs T. J Am Soc Nephrol. 2011 May;22(5):793-5. doi: 10.1681/ASN.2011030284. Epub 2011 Apr 14. J Am Soc Nephrol. 2011. PMID: 21493772 Free PMC article. No abstract available.
The case for a ketogenic diet in the management of kidney disease.
Athinarayanan SJ, Roberts CGP, Vangala C, Shetty GK, McKenzie AL, Weimbs T, Volek JS. Athinarayanan SJ, et al. Among authors: weimbs t. BMJ Open Diabetes Res Care. 2024 Apr 27;12(2):e004101. doi: 10.1136/bmjdrc-2024-004101. BMJ Open Diabetes Res Care. 2024. PMID: 38677719 Free PMC article. Review.
82 results